Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alf Spitschak

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Biomarker Research|April 17, 2026
Cancer in transition: discovery of tumor-intrinsic transcriptional programs shaping the immune and microenvironmental landscapeAlf Spitschak, Rosaely Casalegno Garduño, Brigitte M Pützer
Biomolecules|January 28, 2026
Integrative Multimodal Profiling of TAp73 and DNp73 Reveals Isoform-Specific Transcriptomic Coregulator Landscapes in Cancer ProgramsSteffen Möller, Alf Spitschak, Nico Murr, et al.
Biomedicines|April 29, 2025
CD8+ T Cell Subsets as Biomarkers for Predicting Checkpoint Therapy Outcomes in Cancer ImmunotherapyRosaely Casalegno Garduño, Alf Spitschak, Tim Pannek, et al.
Clinical Endocrinology|June 30, 2011
Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation?Andreas Machens, Alf Spitschak, Kerstin Lorenz, et al.
Seminars in Cancer Biology|July 4, 2018
Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasisStephan Marquardt, Manish Solanki, Alf Spitschak, et al.
Molecular Cancer|January 27, 2017
MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuitAlf Spitschak, Claudia Meier, Bhavani Kowtharapu, et al.
Pharmaceutics|January 21, 2023
Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune DiseaseAlf Spitschak, Shailendra Gupta, Krishna P Singh, et al.
Frontiers in Cell and Developmental Biology|October 15, 2021
Mechanisms of Functional Pleiotropy of p73 in Cancer and BeyondStella Logotheti, Christin Richter, Nico Murr, et al.
Placenta|February 15, 2020
Adenoviral mediated expression of anti-inflammatory progranulin by placental explants modulates endothelial cell activation by decrease of ICAM-1 expressionJohannes Stubert, Marlen Szewczyk, Alf Spitschak, et al.
Nucleic Acids Research|September 10, 2015
Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signaturesYajie Wang, Vijay Alla, Deborah Goody, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Biomarker Research|April 17, 2026
Cancer in transition: discovery of tumor-intrinsic transcriptional programs shaping the immune and microenvironmental landscapeAlf Spitschak, Rosaely Casalegno Garduño, Brigitte M Pützer
Biomolecules|January 28, 2026
Integrative Multimodal Profiling of TAp73 and DNp73 Reveals Isoform-Specific Transcriptomic Coregulator Landscapes in Cancer ProgramsSteffen Möller, Alf Spitschak, Nico Murr, et al.
Biomedicines|April 29, 2025
CD8+ T Cell Subsets as Biomarkers for Predicting Checkpoint Therapy Outcomes in Cancer ImmunotherapyRosaely Casalegno Garduño, Alf Spitschak, Tim Pannek, et al.
Clinical Endocrinology|June 30, 2011
Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation?Andreas Machens, Alf Spitschak, Kerstin Lorenz, et al.
Seminars in Cancer Biology|July 4, 2018
Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasisStephan Marquardt, Manish Solanki, Alf Spitschak, et al.
Molecular Cancer|January 27, 2017
MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuitAlf Spitschak, Claudia Meier, Bhavani Kowtharapu, et al.
Pharmaceutics|January 21, 2023
Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune DiseaseAlf Spitschak, Shailendra Gupta, Krishna P Singh, et al.
Frontiers in Cell and Developmental Biology|October 15, 2021
Mechanisms of Functional Pleiotropy of p73 in Cancer and BeyondStella Logotheti, Christin Richter, Nico Murr, et al.
Placenta|February 15, 2020
Adenoviral mediated expression of anti-inflammatory progranulin by placental explants modulates endothelial cell activation by decrease of ICAM-1 expressionJohannes Stubert, Marlen Szewczyk, Alf Spitschak, et al.
Nucleic Acids Research|September 10, 2015
Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signaturesYajie Wang, Vijay Alla, Deborah Goody, et al.
Pageof 3